About Morningside Pharmaceuticals
Morningside Pharmaceuticals is a Healthcare company based in Loughborough (United Kingdom) founded in 1991, and was acquired by Aspire Pharma in October 2022. Healthcare products are distributed diversely across sectors by Morningside Pharmaceuticals. Morningside Pharmaceuticals has completed 1 acquisition, including Aspire Pharma. Its chief executive, as recorded, is Nik Kotecha. Morningside Pharmaceuticals offers products and services including Generic Medicines and Branded Medicines. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is MORNINGSIDE PHARMACEUTICALS LIMITED. Its competitors include Target Healthcare, Lexon UK and Mawdsleys; 1 of its 3 listed competitors has raised funding.
Company details
Morningside Pharmaceuticals was established in 1991 in Loughborough, United Kingdom. Operations are centered on the distribution of healthcare products within the pharmaceutical sector. Diversification is pursued through a range of services, including supply chain management for medical goods. The company is led by CEO Nik Kotecha, with activities primarily based in the UK market. Focus is maintained on reliable healthcare logistics without expansion into manufacturing.
- Headquarters Loughborough, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website morningsidepharm.com
- Social LinkedIn
- Acquired by Aspire Pharma (Oct 2022)
- Legal Name Morningside Pharmaceuticals Limited
- Date of Incorporation 18 Dec, 1991
- Jurisdiction NORTHAMPTON, ENGLAND
- Investors
- Investments & Acquisitions
- Acquired byAspire Pharma
(Oct 2022)
Products & Services of Morningside Pharmaceuticals
Morningside Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Medicines and Branded Medicines.
Manufactures and supplies affordable generic drugs for global markets
Provides high-quality branded healthcare products internationally
Investors in Morningside Pharmaceuticals
Morningside Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Aspire Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutic drugs and medical devices are in-licensed and commercialized. | 2009 | aspirepharma.co.uk | Petersfield, United Kingdom |
Investor details for Morningside Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Morningside Pharmaceuticals
1 people are tracked at Morningside Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
Nik Kotecha | CEO | Leadership |
Complete people profiles for Morningside Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Morningside Pharmaceuticals
Morningside Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aspire Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutic drugs and medical devices are in-licensed and commercialized. | aspirepharma.co.uk | Petersfield, United Kingdom | 2009 | Oct 2022 | β’β’β’β’ |
Complete acquisition details for Morningside Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Morningside Pharmaceuticals
3 dated milestones of Morningside Pharmaceuticals across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Morningside Pharmaceuticals is founded.
- Acquisition Acquires Aspire Pharma.
- Exit Acquired by Aspire Pharma.
Competitors of Morningside Pharmaceuticals
Morningside Pharmaceuticals has 3 listed competitors in our database, 1 of them funded. They include Target Healthcare, Lexon UK and Mawdsleys.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| lexonuk.com | 1995 | Birmingham, United Kingdom | Pharmaceutical drugs are distributed diversely across markets by Lexon UK. | |||
| mawdsleys.co.uk | 1825 | Manchester, United Kingdom | Provides pharmaceutical wholesale, distribution, logistics, and fulfilment services to healthcare entities. |
Detailed competitors of Morningside Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Morningside Pharmaceuticals
The website of Morningside Pharmaceuticals (morningsidepharm.com) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 220.5% vs previous month
Websites whose visitors overlap most with Morningside Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mawdsleys.co.uk | 100% | 2.9K | #6,990,885 | View details | |
accord-healthcare.com | accord-healthcare.com | 99% | #1,035,209 | β | |
meritpharm.com | meritpharm.com | 87% | #1,269,208 | β | |
| united-drug.com | 81% | 6.2K | View details | ||
pdpharm.co.uk | pdpharm.co.uk | 81% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 27 similar websites and full traffic analytics for Morningside Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Morningside Pharmaceuticals
Complete news archive for Morningside Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morningside Pharmaceuticals
Morningside Pharmaceuticals was founded in 1991.
Morningside Pharmaceuticals is headquartered in Loughborough, United Kingdom. It is registered at Loughborough, England, United Kingdom.
Nik Kotecha is the CEO of Morningside Pharmaceuticals, as recorded in our data.
Morningside Pharmaceuticals was established in 1991 in Loughborough, United Kingdom. Operations are centered on the distribution of healthcare products within the pharmaceutical sector. Diversification is pursued through a range of services, including supply chain management for medical goods. The company is led by CEO Nik Kotecha, with activities primarily based in the UK market. Focus is maintained on reliable healthcare logistics without expansion into manufacturing.
Morningside Pharmaceuticals's top competitors include Target Healthcare, Lexon UK and Mawdsleys.
Morningside Pharmaceuticals offers Generic Medicines and Branded Medicines.
Morningside Pharmaceuticals has made 1 acquisition, including Aspire Pharma.
Morningside Pharmaceuticals has 1 investor. Key investors include Aspire Pharma.
Morningside Pharmaceuticals operates through Morningside Pharmaceuticals Limited.
Yes. Morningside Pharmaceuticals was acquired by Aspire Pharma in October 2022.

